By Deena Beasley April 30 (Reuters) - Amgen on Thursday reported first-quarter product sales rose 4%, helped by demand for ...
Biotech company Amgen (NASDAQ:AMGN) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 5.8 ...
Learn more THOUSAND OAKS, Calif., April 30, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2026. "Our first quarter results demonstrate the ...
The biotechnology company reported a profit of $1.82 billion, driven by a 4% rise in product sales.
Amgen Inc. reported better-than-expected first-quarter results but only minimally raised its profit guidance, a conservative move as the biotechnology company prepares for increasing competition over ...
Investor's Business Daily on MSN
Amgen's numbers are out: It gets to keep its cholesterol crown — for now
Amgen widely beat the Street's first-quarter expectations late Thursday, slightly ticking its 2026 guidance higher.
The Dow Jones Industrial Average is rallying Thursday morning with shares of Caterpillar and Amgen delivering strong returns for the index. Shares of Caterpillar Caterpillar Inc.
Apple — Shares were up 2%. For the fiscal second quarter , Apple's earnings came in at $2.01 per share, while revenue landed ...
Generics battle takes center stage at SCOTUS; FDA uses AI for clinical trial review; Purdue Pharma to dissolve.
April 30, 2026 expert reaction to OBSCORE – a tool to identify individuals at highest risk of obesity-related complications . A study published in Nature Medicine looks at a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results